Compass Health Sciences operates a world-class In Vitro Diagnostics (IVD) manufacturing facility in Visakhapatnam - the City of Destiny.
The Compass manufacturing unit is established on 1 acre of land with a GMP-compliant built-up area of approximately 23,000 sq. ft., designed to meet global manufacturing and regulatory standards.
Compass Health Sciences specializes in the development and manufacture of Rapid Card Tests (POCT) across a wide diagnostic spectrum, supporting blood safety, disease surveillance, and preventive healthcare.
The manufacturing facility is equipped with highly sophisticated automatic cassette assembly and pouching machines, enabling efficient, high-volume, and reproducible manufacturing.
Production capacity: Up to 4 lakh tests per day
Manufacturing standards: WHO-GMP compliant
Designed for rapid scalability and export readiness
Need Any Help?
Keeping India’s diverse population and challenging climatic conditions in mind, Compass diagnostic kits are robustly engineered to perform reliably in high-temperature and high-humidity environments. All products are indigenously designed and developed through strong in-house research and development, reflecting the company’s unwavering commitment to innovation, affordability, and widespread market accessibility.
Compass Health Sciences envisions becoming a comprehensive diagnostics solutions provider, with planned expansion across the diagnostics value chain, including
POCT, ELISA, CLIA, FIA and Molecular diagnostics, including PCR-based nucleic acid tests
The company also aims to indigenously manufacture core laboratory components and medical device equipment like, Biochemistry Analysers, Electrolyte Analyser , Continuous Glucose Monitor, and other Non- Invasive devices further strengthening India’s diagnostics ecosystem
Driven by innovation, quality-focused manufacturing, and global market expansion, Compass Health Sciences targets a business turnover of INR 576 million over the next three years.
Compass Health Sciences is committed to creating meaningful social and public health impact. By enabling early disease detection through affordable diagnostics, the company contributes to improved healthcare outcomes, particularly in resource-limited and high-burden settings.
The manufacturing facility also generates substantial employment opportunities for the local workforce, supports skill development, and contributes to regional and national economic growth. Through domestic expansion and entry into international markets, Compass Health Sciences supports export-led growth and foreign revenue generation.
Quality is embedded across every stage of Compass Health Sciences’ operations. The facility operates under a robust Quality Management System compliant with ISO 13485, along with WHO and GMP guidelines, ensuring the highest standards of safety, performance, and reliability . From raw material qualification and in-process quality checks to final product validation and batch release, all activities are governed by documented procedures and validated processes. Trained personnel, controlled cleanroom environments, and continuous monitoring ensure compliance with national and international regulatory requirements.
This strong quality framework enables Compass Health Sciences to consistently deliver diagnostic solutions that healthcare providers, laboratories, and public health agencies can trust.
Our process begins with in-house research and innovation, focusing on developing accurate, reliable, and affordable diagnostic solutions tailored for diverse healthcare needs.
Using advanced automated systems and GMP-compliant infrastructure, we ensure high-precision production with consistent quality and scalability across all diagnostic products.
Every product undergoes strict quality validation under ISO and WHO-GMP standards before being efficiently packaged and delivered to domestic and global markets.
All raw materials used in manufacturing are completely indigenous, significantly reducing import dependency and enabling the production of cost-effective, high-quality diagnostic solutions. This approach strongly aligns with the Make in India initiative and reinforces India’s self-reliance in medical diagnostics while positioning the company for global markets.
